Home » Topics » Regulatory » Patents

Patents
RSS

Na+/Ca2+ exchange inhibitors patented by Taisho

Nov. 16, 1998

Antiulcer tetrahydropyrido compounds in development at Byk Gulden

Nov. 16, 1998

Taiho isolates new antiproliferative agent from Nocardiopsis strain

Nov. 13, 1998

Antibacterial compounds from Merck act by inhibiting Mur D

Nov. 13, 1998

Hydroxamic acid compounds as inhibitors of TNF production and/or MMPs

Nov. 13, 1998

SCRAS presents new series of NOS and lipid peroxidation inhibitors

Nov. 13, 1998

New compounds from Glaxo Wellcome and their use as beta3-adrenoceptor agonists

Nov. 13, 1998

Protein tyrosine kinase inhibitors for cancer, polycystic kidney disease

Nov. 12, 1998

Preparation and use of new CNS-active series reported by Pharmacia & Upjohn

Nov. 12, 1998

Compounds for influenza developed at Shionogi

Nov. 12, 1998

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...